KRRO.NASDAQKorro Bio, INC

Form 4: Korro Bio CEO Sells Shares for Tax Withholding

Sentiment:

Statement of Changes in Beneficial Ownership


Korro Bio President and CEO Ram Aiyar reported a sale of 15,152 shares of common stock to cover tax obligations related to a performance stock unit settlement.

Summary

  • Ram Aiyar, President and CEO of Korro Bio, Inc., reported a transaction on May 29, 2026.
  • The transaction involved the sale of 15,152 shares of common stock.
  • These shares were sold to satisfy tax withholding obligations arising from the vesting and settlement of a performance stock unit.
  • The sale occurred at a weighted-average price of $12.98 per share, with individual sales ranging from $12.62 to $13.245.
  • Following this transaction, Aiyar directly beneficially owns 74,848 shares of common stock.
  • Additionally, 4,613 shares are held indirectly through The Ram Aiyar Irrevocable Trust, where Aiyar serves as trustee.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the stock sale is attributed to standard tax withholding obligations related to executive compensation, rather than a reflection of negative company performance or outlook.

Positives

  • The sale was conducted to cover tax obligations, indicating a standard procedure for equity compensation settlement.
  • The reporting person, Ram Aiyar, holds a significant number of shares directly (74,848) and indirectly (4,613), demonstrating continued ownership.

Negatives

  • A sale of company stock by a CEO, even for tax purposes, can sometimes be perceived negatively by the market.
  • The weighted-average sale price of $12.98 might be lower than the current market price, though this is not explicitly stated as a negative.

Risks

  • Potential for negative market perception of insider selling, even if for tax purposes.
  • The filing does not detail any specific future risks or challenges for the company.

Future Outlook

No specific forward-looking statements or guidance were provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for executives and directors regarding stock transactions. While this filing details a sale to cover tax obligations, it is important for investors to monitor the overall pattern of insider transactions for any potential shifts in management's confidence in the company's prospects.

Related Party Transactions

  • Shares held by The Ram Aiyar Irrevocable Trust, for which Ram Aiyar serves as trustee, are noted. Ram Aiyar disclaims beneficial ownership except to the extent of his pecuniary interest.

Stakeholder Impact

  • Shareholders: The sale is for tax purposes and does not necessarily indicate a change in management's long-term view of the stock. However, any insider selling can create short-term market sentiment shifts.
  • Employees: The transaction relates to executive compensation, which is a standard component of employee incentive structures.
  • Management: Ram Aiyar, as CEO, is fulfilling his tax obligations related to his compensation package.

Next Steps

  • Continued monitoring of Ram Aiyar's beneficial ownership and any future transactions.
  • Observation of Korro Bio's overall business and financial performance as reported in subsequent filings.

Key Dates

DateDescription
05/29/2026Transaction date for the sale of common stock.
06/02/2026Date of signature for the filing.

Keywords

Korro Bio, KRRO, Form 4, insider trading, stock sale, Ram Aiyar, CEO, tax withholding, performance stock unit, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.